Purity starts with identity
Before asking whether a material is pure, a laboratory must ask: pure of what? Identity testing looks for evidence that the intended chemical entity is present and distinguishes it from plausible alternatives. Depending on the substance, that evidence may combine a reference spectrum, chromatographic retention, elemental or structural information, and orthogonal tests. A label, appearance, or one matching signal is not identity proof by itself.
The word “purity” usually describes the fraction of a defined material attributable to a specified component. An IUPAC technical report on organic compounds describes complementary approaches such as mass balance, quantitative nuclear magnetic resonance, thermal analysis, and direct assays rather than treating one test as universally sufficient [1]. Thus, a result must state what was measured, in which sample, and by which procedure.
A number has a method behind it
Concentration is an amount relative to a stated quantity—such as mass per mass, amount per volume, or amount per material volume. It is not interchangeable with purity. A solution can have a precisely known concentration of a substance that contains an unmeasured impurity; a solid can have a high reported mass fraction while its concentration in a particular preparation depends on weighing, dilution, and homogeneity.
Analytical procedures are validated for a purpose. FDA’s Q2(R2) guidance distinguishes procedures used for identity, assay, purity, and quantitative or limit tests for impurities, and discusses characteristics including specificity, accuracy, precision, linearity, range, detection limit, and quantitation limit [2]. A method that can measure a major component accurately may be poorly suited to finding a minor contaminant, an isomer, a degradation product, or a substance that responds differently in the instrument.
Impurities, contamination, and blind spots
Impurities may arise from synthesis, extraction, storage, degradation, solvents, catalysts, packaging, or the environment. Contamination can enter during sampling and preparation, from glassware, reagents, air, carryover, or the instrument itself. Some signals are not contaminants in the original material at all: they may be introduced during handling or formed during analysis. Controls such as blanks, replicate preparations, reference materials, calibration checks, and documented sample custody help separate these possibilities.
Every technique has a visibility limit. In liquid-chromatography mass spectrometry, coexisting components can suppress ionization and reduce a signal; variable matrix effects can make quantitative results unreliable unless the method evaluates and controls them [3]. A non-detected impurity therefore means “not detected under the stated conditions and limit,” not “proven absent.” Different methods can legitimately produce different purity estimates because they see different chemical features.
Traceability makes a result interpretable
Traceability is the documented connection between a measurement result and a reference through an unbroken chain of calibrations, each contributing to uncertainty. IUPAC’s recommendations link analytical quality assurance with calibration, validation, measurement uncertainty, and interlaboratory comparison [4]. In practice, useful records identify the sample and lot, collection date, preparation, instrument, method version, calibration materials, controls, analyst, calculations, and uncertainty or reporting limit.
This chain does not make a sample metaphysically “pure.” It makes a claim auditable: someone else can understand what was tested, compare the result with a stated specification, and judge whether the method was fit for that question. Confidence grows when independent methods agree and when controls behave as expected, but agreement still concerns the tested properties and conditions.
What verification can—and cannot—say
Scientific verification can support claims such as “the intended identity was consistent with these tests,” “the measured concentration was approximately this value,” or “specified impurities were below this method’s reporting limit.” It cannot establish that every possible impurity is absent, that a sample is homogeneous throughout, or that a result remains true after transport, storage, or reformulation. Sampling error, degradation, matrix effects, calibration error, and inadequate specificity can all limit interpretation.
Most importantly, chemical verification cannot establish clinical safety or efficacy. Those questions require appropriate toxicology, pharmacology, clinical research, dose and exposure data, and regulatory assessment—evidence that a purity or identity report does not provide. The scientifically honest conclusion is bounded: a result is only as strong as the question, sample, method, controls, and traceability supporting it.
TAKE THE IDEA WITH YOU
Key takeaways
- Purity is a defined measurement of a specified component, not a universal guarantee; identity and concentration are related but different questions.
- A method’s specificity, sensitivity, matrix effects, reporting limits, controls, and traceability determine what an analytical result can support.
- Verification can characterize tested chemical properties, but it cannot establish clinical safety, efficacy, or the absence of every possible contaminant.
What this explanation cannot establish
This is independent educational context, not a laboratory report, regulatory determination, clinical assessment, or substitute for professional advice. No sample was tested here, and no claim is made about any specific material, lot, product, method performance, or laboratory. The cited sources describe general analytical practice; applicability depends on the analyte, matrix, sampling plan, instrument, validated method, reference materials, reporting limits, and uncertainty. Non-detection is bounded by the method’s detection capability, and chemical verification cannot establish clinical safety or efficacy.
General scientific education. Not diagnosis, treatment advice, product guidance, or evidence for any material’s suitability for human use.
References & further reading
- Methods for the SI-traceable value assignment of the purity of organic compounds (IUPAC Technical Report)
This technical report describes purity value assignment and the applicability of mass balance, quantitative NMR, thermal methods, and direct methods; it supports the distinction between a defined purity value and a universal notion of purity.
- Q2(R2) Validation of Analytical Procedures
FDA guidance covers analytical procedures for identity, assay, purity, and impurity tests and explains validation characteristics such as specificity, accuracy, precision, detection limit, and quantitation limit.
- Principles and Applications of Liquid Chromatography-Mass Spectrometry in Clinical Biochemistry
This accessible NCBI article explains ion suppression, matrix-dependent sensitivity, variable suppression, and limits on direct-injection LC-MS quantitation and discrimination.
- Metrological and quality concepts in analytical chemistry (IUPAC Recommendations)
IUPAC defines the analytical metrology and quality-assurance concepts underlying calibration, measurement uncertainty, validation, quality control, and traceability.
Sources accessed during preparation on 12 October 2026. Claims are bounded by each source’s methods and scope. Share a correction or a general science question through the question form.
